MindRank AI Targets Selective CB1 Receptor Modulation With Novel Heterocyclic Compounds
The patent disclosure describes novel synthetic heterocyclic molecules engineered to selectively regulate cannabinoid CB1 receptor activity. Developed utilizing computational drug design, these active pharmaceutical ingredients aim to fine-tune receptor…
New Cannabis Cultivar 4D2 Secures Patent for Varin and Classical Cannabinoids
The patent disclosure protects a proprietary annual herbaceous cannabis variety, designated '4D2', created through sexual hybridization. The cultivar is chemically distinguished by its simultaneous production of four key cannabinoids:…
Cryogenic Processing Claims Advance Nanoparticle Formulations for Enhanced Cannabinoid Delivery
The patent application outlines a method using low-temperature cryogenic processing to engineer cannabinoid nanoparticles and specialized delivery compositions. This process aims to protect thermally sensitive active compounds while yielding ultra-fine…
Sapienza University Patent Signals New Horizons for Specialized Cannabis Extract Formulations
The patent disclosure outlines proprietary extraction techniques and chemical compositions focused on specific dibenzopyran derivatives and isolated phytocannabinoid fractions. Developed by prominent Italian cannabinoid researchers, the platform focuses…
Advanced Cellulose Filters Target Tars in Combustible Cannabis Pre-Rolls
The patent disclosure covers specialized cellulose-based filter architectures engineered for cannabis smoking articles such as pre-rolls. The claimed filtration substrates focus on trapping particulate matter and heavy combustion byproducts while…
Patent Watch: Metrc Claims Data-Driven Cannabis
US20260094116A1 describes a system for establishing industry norms and recording regulated cannabis across cultivation, production, harvest, and packaging. Its disclosed embodiment treats recorded products as legal and unrecorded products as illegal,…
Patent Watch: Vertosa Targets More Predictable Cannabis
The application’s title indicates an effort to control the pharmacodynamics, or biological effects, of cannabis-infused edible products and medicines. The available disclosure does not identify specific cannabinoid active pharmaceutical ingredients,…
Patent Watch: Esolate Targets Solid Oral CBD Formulations
US20260097052A1 describes pharmaceutical formulations containing cannabidiol (CBD), including solid oral dosage forms, along with manufacturing methods and therapeutic uses. CBD is the active pharmaceutical ingredient, while the available disclosure does…
Patent Watch: NUS Targets Cannabinoid Biosynthesis With
The application identifies novel cannabinoid synthases for producing cannabinoids from cannabigerolic acid (CBGA), a precursor in cannabinoid biosynthesis. This is a manufacturing approach rather than a finished drug formulation or delivery system: the…
Patent Watch: Avecho Targets Oral Cannabinoid Delivery
Avecho’s application describes an oral cannabinoid formulation combining tocopheryl phosphates with long-chain triglycerides or long-chain fatty acids. Cannabinoids are the intended active pharmaceutical ingredients, while the accompanying compounds…
